News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pro-Pharmaceuticals, Inc. (PRW) Collaborates With Chemwerth USA To Scale-up Production Of DAVANAT(R) For Initial Marketing Needs



2/20/2007 12:58:48 PM

NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel carbohydrate compounds, today announced it is collaborating with Chemwerth, Inc. to scale-up production of its lead drug candidate, DAVANATĀ® to 100 kilograms for initial marketing needs. DAVANATĀ® is a carbohydrate polymer composed of mannose and galactose (galactomannan). Chemwerth, Inc. is an Active Pharmaceutical Ingredient (API) development and supply company specializing in generic drugs that include oral, injectable, topical and veterinary products.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES